Site icon PNI

Samsung Announces New Medications Tracking Feature for Samsung Health in India

Gurugram: India’s largest consumer electronics brand, Samsung announced that it has added the Medications tracking feature1 to the Samsung Health app2 to help users manage their health more comprehensively.

The feature will not only allow users to keep track of their prescribed or over-the-counter medication regime but will also offer important medical information and tips. The feature can help in tracking medication adherence consistency for those, who are on a medication journey for hypertension, diabetes, PCOS, PCOD and other chronic diseases that require timely doses.

“Samsung is a brand that puts its customers first and continuously works on products and services to improve their daily lives. We aim to build a holistic health platform for people to understand and manage their health better by connecting devices and services. With the addition of Medications feature for India in the Samsung Health app, we believe users will be able to manage their medications more conveniently, improve adherence, and ultimately maintain better health,” said Kyungyun Roo, Managing Director, Samsung Research Institute, Noida.

The Medications feature, the result of a collaborative effort between R&D, Design and Consumer Experience teams at Samsung, has been designed keeping in mind the needs of Indian consumers. Upon entering the name of a select medication into the Samsung Health app, the Medications feature will provide users with detailed information including general descriptions, as well as its possible side effects.

In addition, the new feature will provide information on adverse reactions from drug-to-drug interactions and other relevant safety guidance. Users can set up alerts to remind them both when to take their medications and when to refill them seamlessly through the

Samsung Health App.

These alerts can be fine-tuned to the need of the individual user, so the medications can be prioritized depending on their importance to the user, with Samsung Health sending reminders ranging from “gentle” to “strong”. Galaxy Watch users will also receive reminders right on their wrist so they can stay on top of their medication schedules, even when away from their phones.

The Samsung Health app already provides a range of advanced health offerings spanning sleep management3, mindfulness programmes and irregular heart rhythm notification4 capabilities. The introduction of the Medication tracking feature in India will further reinforce Samsung’s commitment to create holistic wellness experiences for its users, enabling them to lead healthier, more fulfilling lives.

The Medications tracking feature will be available on the Samsung Health app in India via the app updates.

  1Samsung Health Medications feature is intended to help users manage their medication list and schedule. Information provided is evidence-based content licensed from Tata 1mg.

2Requires smartphone with Android 10.0 or later and Samsung Health app version 6.28 or later. Availability for the features may vary by device.

3Sleep features are intended for general wellness and fitness purposes only. The measurements are for your personal reference only. Please consult a medical professional for advice.

4The IHRN feature is only available in select markets. Available on Wear OS devices version 4.0 or later. It is not intended to provide a notification on every episode of irregular rhythm suggestive of AFib and the absence of a notification is not intended to indicate no disease process is present. It is not intended for users with other known arrhythmias. The features are supported via the Samsung Health Monitor app. Availability may vary by market or device. Due to market restrictions in obtaining approval/registration as a Software as a Medical Device (SaMD), it only works on watches and smartphones purchased in the markets where service is currently available (however, service may be restricted when users travel to non-service markets). This app can only be used for measuring in ages 22 and over.

Exit mobile version